The page is the record's research on the issuer — no analyst, no rating, no view. # Definium Therapeutics, Inc. (NASDAQ: DFTX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Definium Therapeutics, Inc., listed on NASDAQ under ticker DFTX, with ISIN US24477V1052. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-A1. The security type is Corporate, the segment is not on the record, the sector is 2833 Medicinal Chemicals & Botanical Products, and the jurisdiction is British Columbia, Canada. The issuer is listed and not halted. ## The disclosure read The record holds 95 filings in the window from 2025-11-08 to 2026-11-08, across 34 filing days. The median gap between filing days is 6 days. The latest filing is dated 2026-11-05, 3 days before the record date of 2026-11-08, and its type is regulatory_filing. The NASDAQ median gap between filing days is 6.0 days, and the issuer's gap is equal to it. The NASDAQ median filings in the window is 52, and the issuer's count is below it. The NASDAQ median latency is 5.0 days, and the issuer's latency is below it. The sector median gap between filing days is 7.2 days, and the issuer's gap is below it. The sector median filings in the window is 40.0, and the issuer's count is above it. The sector median latency is 4.5 days, and the issuer's latency is below it. By type, the window holds 47 directors_dealings, 27 regulatory_filing, 8 corporate_news, 7 results, 2 agm_egm, 2 director_change and 2 prospectus filings. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The chapter is as of 2026-11-04. ## Coverage The record finds no research houses named on the issuer's investor-relations page, and the count is 0. ## Open research The record finds no openly published research notes for the issuer. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001813814.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/DFTX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/DFTX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/DFTX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp